XYZAL ALLERGY 24HR FDA approval date
The FDA approved XYZAL ALLERGY 24HR on 31 Jan 2017.
- FDA approval date
- 31 Jan 2017
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as LEVOCETIRIZINE DIHYDROCHLORIDE
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2017-01-31Day | XYZAL ALLERGY 24HR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA209089", "applicant_as_listed_by_fda": "CHATTEM SANOFI", "brand_names": ["XYZAL ALLERGY 24HR"], "active_ingredients": ["LEVOCETIRIZINE DIHYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170131", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |